서브이미지

About Us

History

Growth

  • Listed on the KOSDAQ market in 2015.
  • Acquisition of Sungwoon Bio in 2017 (currently GF Permanentech)
Growth 이미지
Technology
- Efficient special enzyme development process (3 years -> 1 year)
- 150 tons industrial fermentation production
Sales
Securing excellent customers and launching special enzymes.
Leaping into a biotherapeutics developing company.
2020
  • 08 Development of human disease models such as IBD and Wet AMD in mini pigs.
  • 08 Development of Proteinase-K, an essential enzyme for COVID-19 diagnosis.
  • 02 10 billion won worth of investment attraction.
2018
  • 10 Establishment of BiomLogic, a subsidiary specializing in new drug development.
2017
  • 06 Discovered GF103 as a candidate for pharmaceutical products.
  • 03 Acquisition of Sungwoon Bio (Currently GF Fermentech)
2016
  • 11 Lactase US FDA GRAS acknowledged.
  • 10 30.8 billion won worth of investment attraction.
2015
  • 05 KOSDAQ Market Listed
2013
  • 08 Hydrogen peroxide decomposing enzyme in semiconductor factory cleaning solution. Sales of Katalase S 350L started.
2012
  • 05 Establishment of 100% subsidiary in China. (GenoFocus Biotechnology Ltd.)

Take-off

  • Development of Catalase mass production process in 2010
Take-off 이미지
technology
Customized enzyme development and production technology.
- Enzyme improvement technology
- recombinant protein secretion technology
sales
Service & customized enzyme.
2011
  • 11 Katalase S sales started. Hydrogen peroxide decomposing enzyme for the use in fibers.
  • 10 Technology transfer of GOS production to company Q (USD 600,000)
2010
  • 11 Completed development of TL Lipase production technology for manufacturing raw medicinal material.
  • 11 Catalase mass production process development completed.
2008
  • 12 Selected for civil and military technology development project (Defense Acquisition Program Administration): developing eco-friendly decontamination agents for chemical/biological weapons.

Establishment

  • 2001 Certified as a venture company.
  • 2002 Selected as INNO-BIZ company.
Establishment 이미지
Technology
Customized protein development platform tech.
- Molecular evolution technology
- Microbial surface display technology
sales
Technology service.
2004
  • 10 2 nd CEOinauguration:EuiJoongKim
2002
  • 12Selected as INNO-BIZ company
2001
  • 05 Selected as national designated laboratory by Ministry of Science and ICT: Microbial surface display platform technology.
  • 02 Certified as venture company
2000
  • 03Korea Research Institute of Bioscience and Biotechnology spin-off founded.
    (Founder: Jae-Gu Pan, current CTO)